From: Modifiable risk factors in women at high risk of breast cancer: a systematic review
Author | Race/ethnicity data |
---|---|
BRCA studies | |
Cybulski et al. [8] | NR. Study subjects from 12 countries |
Dennis et al. [6] | Ethnicity. Controls: French-Canadian 133 (6.9%), Jewish 359 (18.7%), Other 31 (1.6%), Other White 1402 (72.8%). Cases: French-Canadian 150 (7.8%), Jewish 284 (14.8%), Other 55 (2.9%), Other White 1436 (74.6%). Study subjects from 8 countries |
Ghadiriani et al. [25] | NR. Study subjects from 11 countries |
McGuire et al. [7] | Study subjects were non-Hispanic white women. Involved institutions from US, Canada, and Australia |
Kotsopoulos et al. [44] | Ethnicity. Controls: Other white 367 (85.0%), Jewish 51 (11.8%), French-Canadian 9 (2.1%), Other 5 (1.2%). Cases: Other white 350 (81.0%), Jewish 53 (12.3%), French-Canadian 13 (3.0%), Other 16 (3.7%). Study subjects from 13 countries |
Lee et al. [45] | Race and ethnic origin. Controls: White 409 (92%), African-American 35 (8%), not Ashkenazi Jewish 398 (90%), are Ashkenazi Jewish 46 (10%). Cases who are BRCA1/2 mutation carriers: White 88 (94%), African-American 6 (6%), not Ashkenazi Jewish 69 (73%), are Ashkenazi Jewish 25 (27%). Cases who are BRCA1/2 mutation noncarriers: White 1239 (90%), African-American 136 (10%), not Ashkenazi Jewish 1222 (89%), are Ashkenazi Jewish 153 (11%). Study conducted in US |
Park et al. [46] | NR, but study conducted in Korea |
Toss et al. [47] | NR, but study conducted in Italy |
Eisen et al. [48] | Ethnicity. Controls: Other white 233 (82%), Jewish 53 (14%), French-Canadian 15 (3%), Other 2 (1%). Cases: Other white 183 (73%), Jewish 40 (17%), French-Canadian 10 (4%), Other 3 (1%). Subjects from 9 countries |
Gronwald et al. [27] | NR, but study conducted in Poland |
Haile et al. [49] | Eligible subjects were White non-Hispanic women. Sources from US, Canada and Australia |
Heimdal et al. [50] | NR, but study conducted in Norway |
Brunet et al. [26] | NR. Study conducted in North America (women resided in either Canada or US) |
Ginsburg et al. [23] | NR. Study subjects from 11 countries |
Grill et al. [9] | NR but study conducted in Germany |
Kim et al. [37] | NR. Study subjects from 17 countries |
Ko et al. [22] | NR. The study population was selected from a multicenter longitudinal cohort of BRCA1 and BRCA2 mutation carriers from 80 participating centers in 17 countries including North America, Europe, Asia, the Caribbean, and Latin America |
Kotsopoulos et al. [51] | NR. Study subjects from 5 countries |
Lammert et al. [52] | NR. Study subjects from 17 countries |
Lecarpentier et al. [40] | NR but study conducted in France |
Manders et al. [53] | NR but study conducted in the Netherlands |
Nkondjock et al. [10] | Participants were French-Canadian. Study conducted in Canada |
Pijpe et al. [41] | NR but study conducted in the Netherlands |
Qian et al. [42] | Ethnicity. BRCA1 carriers: Caucasian not otherwise specified 13,435 (91.5%). Ashkenazi Jewish 1241 (8.5%). BRCA2 carriers: Caucasian not otherwise specified 7126 (90.1%). Ashkenazi Jewish 786 (9.9%). International study with multiple countries of enrollment |
Whittemore et al. [24] | Eligible subjects were non-Hispanic white women. Study subjects from US, Canada, Australia, and New Zealand |
Narod et al. [54] | Ethnicity. Controls: Black 14 (1.1%), French-Canadian 97 (7.4%), Jewish 391 (29.8%), Other non-whites 6 (0.5%), Other whites 801 (61.1%), Missing 2 (0.1%). Cases: Black 28 (2.1%), French-Canadian 99 (7.6%), Jewish 414 (31.6%), Other non-whites 11 (0.8%), Other whites 754 (57.4%), Missing 5 (0.4%). Study subjects from 11 countries |
Bernholtz et al. [55] | All participants were Jewish. Study conducted in Israel |
Brohet et al. [43] | NR. International cohort representing many European countries and Canada |
Kotsopoulos et al. [56] | Ethnicity. Controls: French-Canadian 86 (3.5%), Jewish 419 (16.8%), Other white 44 (1.8%). Cases: French-Canadian 97 (3.9%), Jewish 372 (14.9%), Other white 87 (3.5%). Study subjects from 13 countries |
Schrijver et al. [38] | NR. Combined multiple international cohort studies conducted in Western countries |
Lecarpentier et al. [11] | NR but study conducted in France |
Kehm et al. [39] | Race and ethnicity reported by quintiles of age-adjusted baseline recreational physical activity. Q1: non-Hispanic White 2350 (75.4%), other 745 (23.9%), missing 23 (0.7%). Q2: non-Hispanic white 2451 (78.9%), other 626 (20.2%), missing 30 (1.0%). Q3: non-Hispanic white 2506 (80.5%), other 582 (18.7%), missing 27 (0.9%). Q4: non-Hispanic white 2426 (78.1%), other 652 (21.0%), missing 29 (0.9%). Q5: non-Hispanic white 2418 (77.9%), other 662 (21.3%), missing 23 (0.7%). Used data from studies from US, Canada, Australia, and New Zealand |
Grandi et al. [57] | NR but study conducted in Italy |
Family history of breast cancer studies | |
Bernstein et al. [58] | Race. Cases: White 2933 (64.6%), Black 1605 (35.4%). Controls: White 3003 (64.6%), Black 1656 (35.4%). Study conducted in US |
Gong et al. [59] | All women were African-American. Study conducted in US |
Hirose et al. [60] | NR, but study was conducted in Japan |
Marchbanks et al. [61] | Race. Cases: white race 2953 (64.5%), black race 1622 (35.5%). Controls: white race 3021 (64.5%), black race 1661 (35.5%). Study conducted in US |
Nichols et al. [62] | 94.8% white (1799 cases, 7605 controls). Study conducted in US |
Nyante et al. [31] | NR. Study conducted in US |
Patel et al. [63] | Race. Cases: White 475 (83.4%), Black 92 (16.2%). Controls: White 364 (59.1%), Black 252 (40.9%). Study conducted in US |
Reynolds et al. [32] | The cohort is predominantly non-Hispanic white (87%). Study conducted in US |
Sprague et al. [64] | NR. Study conducted in US |
Murray et al. [65] | Race. First-degree family history cases: White 88.1%, Hispanic 2.5%, Black 6.5%, Other 2.9%. First-degree family history controls: White 87.8%, Hispanic 1.5%, Black 8.7%, Other 2.0%. Second-degree family history cases: White: 90.0%, Hispanic: 1.3%, Black 7.5%, Other 1.3%. Second-degree family history controls: White 90.9%, Hispanic 1.9%, Black 6.4%, Other 0.9%. Study conducted in US |
Newcomb et al. [66] | NR. Study conducted in US |
Silvera et al. [67] | NR. Study conducted in Canada |
Bardia et al. [68] | NR. Study conducted in US |
Brinton et al. [30] | NR. Study conducted in US |
Colditz et al. [20] | NR. Study conducted in US |
Egan et al. [14] | NR. Study conducted in US |
Gram et al. [33] | NR, but study conducted in Norway and Sweden |
Hirose et al. [69] | NR, but study conducted in Japan |
La Vecchia et al. [15] | NR, but study conducted in Italy |
Magnusson et al. [70] | NR, but study conducted in Sweden |
Nomura et al. [19] | NR. Study conducted in US |
Peplonska et al. [71] | NR, but study conducted in Poland |
Swerdlow et al. [72] | NR. Study subjects from Denmark, England and Wales, Finland, and Sweden |
Ursin et al. [73] | NR. Study conducted in US |
Weiderpass et al. [74] | NR, but study conducted in Norway and Sweden |
UK National Case–Control Study Group [75] | NR. Study conducted in UK |
Colditz et al. [21] | NR. Study conducted in US |
Harris et al. [76] | NR. Study conducted in US |
Lipnick et al. [77] | NR. Study conducted in US |
Olsson et al. [78] | NR, but study conducted in Sweden |
Paul et al. [79] | Ethnic group. Cases: Non-Maori 829, Maori 62. Controls: Non-Maori: 1774, Maori 90. Study conducted in New Zealand |
Tavani et al. [80] | NR, but study conducted in Italy |
No author listed (Division of Reproductive Health, Centers for Disease Control) [81] | Race. Cases: White 81.7%, Black 11.8%, Other 6.5%. Controls: White 83.1%, Black 10.8%, Other 6.1%. Study conducted in US |
Claus et al. [82] | Ethnicity. Cases: White 762 (87.1%), Black 57 (6.5%), Other 21 (2.4%), Missing 35 (4.0%). Controls: White 912 (91.3%), Black 54 (5.4%), Other 22 (2.2%), Missing 11 (1.1%). Study conducted in US |
Rohan et al. [83] | NR. Study conducted in Australia |
Lando et al. [84] | Race. White 85.4%, Black 13.8%, Other 0.8%. Study conducted in US |
Nomura et al. [85] | Cases: Japanese 183, Caucasian 161. Same for hospital and neighborhood controls. Study conducted in US |
Sellers et al. [86] | NR. Study conducted in US |
White et al. [12] | Race/ethnicity. Low alcohol consumption: non-Hispanic white 17,181 (83.1%), other 3488 (16.9%). Medium alcohol consumption: non-Hispanic white 14,314 (89.1%), other 1744 (10.9%). High alcohol consumption: non-Hispanic white 4682 (91.1%), other 455 (8.9%). Study subjects from US or Puerto Rico |
Brinton et al. [87] | Because most of the individuals participating in the BCDDP were white, the present analysis was restricted to the 405 cases of breast cancer detected among white women (91.4% of the total respondents) and to the 1,156 white controls. Study conducted in US Religion. Cases: 10.9% Jewish. Controls: 12.9% Jewish |
Carpenter et al. [88] | NR. Study conducted in US |
Cerhan et al. [89] | NR. Study conducted in US |
Couch et al. [29] | The initial study was restricted to Caucasian women because very few minority women were available for meaningful analysis. Study conducted in US |
Dinger et al. [90] | NR but study conducted in Germany |
Grabrick et al. [91] | NR. Study conducted in US |
Jones et al. [28] | NR. Study conducted in the UK |
Katsouyanni et al. [17] | NR but study conducted in Greece |
Kim et al. [18] | NR. Study conducted in US |
Niehoff et al. [92] | Race/ethnicity. < 1 h per week of physical activity: non-Hispanic white 13,601 (79.1%), non-Hispanic black 1890 (11.0%), Hispanic 1197 (7.0%), other 503 (2.9%), missing 1. 1–6 h per week of physical activity: non-Hispanic white 24,897 (85.7%), non-Hispanic black 2284 (7.9%), Hispanic 1162 (4.0%), other 697 (2.4%), missing 6. ≥ 7 h per week of physical activity: non-Hispanic white 3892 (87.7%), non-Hispanic black 274 (6.2%), Hispanic 144 (3.3%), other 126 (2.8%), missing 2. Study conducted in US and Puerto Rico |
Peters et al. [93] | Race/ethnicity. White 89.9%, Black 5.5%, Hispanic 1.9%, Asian/Pacific Islander/Native American 1.5%. Study conducted in US |
Sellers et al. [94] | NR. Study conducted in US |
Suzuki et al. [34] | NR but study conducted in Japan |
Tehard et al. [95] | NR but study conducted in France |
Vachon et al. [16] | NR. Study conducted in US |
Verloop et al. [96] | NR but study conducted in the Netherlands |
Brinton et al. [97] | Only used white study subjects. Study conducted in US |
White et al. [98] | All cases and controls were white. Study conducted in US |
Ravnihar et al. [99] | NR but study conducted in Slovenia |
Pesch et al. [100] | All cases and controls were of Caucasian ethnicity. Study conducted in Germany |
Huang et al. [13] | NR but study conducted in Japan |